1.Department of Genetics, Aix-Marseille University, Marseille; marina.lafage@ap-hm.fr (ML), Service dHistologie-Embryologie-Cytogénétique, Unité de Cytogénétique Onco-Hématologique, Hôpital Universitaire Necker-Enfants Malades, 75015 Paris, France; franck.viguie@aphp.fr.2.MLL Münchner Leukümielabor GmbH, Max-Lebsche-Platz 31, 81377 München, Germany
Review on Acute promyelocytic leukemia, with data on clinics and the genes involved.
FAB criteria AML M3v
Immunophenotype
WHO classification (2008, updated 2016)
Marina Lafage ; Marina Lafage
M3/M3v acute myeloid leukemia (AML M3/M3v) Acute promyelocytic leukemia (APL) Acute promyelocytic leukemia (APL) PML/RARA
Atlas Genet Cytogenet Oncol Haematol. 2017-04-01
Online version: http://atlasgeneticsoncology.org/haematological/1240/m3-m3v-acute-myeloid-leukemia-(aml-m3-m3v)-br-acute-promyelocytic-leukemia-(apl)-br-acute-promyelocytic-leukemia-(apl)-pml-rara
2006-01-01 M3/M3v acute myeloid leukemia (AML M3/M3v) Acute promyelocytic leukemia (APL) Acute promyelocytic leukemia (APL) PML/RARA by Claudia Schoch  Affiliation